1-4 of 4
Helen Brady
Close
Sort by
Journal Articles

Lenalidomide Enhances Anti-Tumor Effect of γδ T Cells against Mantle Cell Lymphoma

Svetlana Gaidarova, Laura G Corral, Emilia Gleizer, David Young, Helen Brady, Brydon Bennett, Antonia Lopez-Girona
Journal: Blood
Blood (2008) 112 (11): 2616.
https://doi.org/10.1182/blood.V112.11.2616.2616
Published: 2008
Journal Articles

New Approaches to the Regulation of Erythropoiesis and Hematoglobin Synthesis in β-Hemoglobinopathies: Studies with the Immunomodulatory Drug CC-4047.

Laure A. Moutouh de Parseval, MD, Dominique Verhelle, Ph.D., Emilia Glezer, B.S., Helen Brady, Ph.D., Laura G. Corral, M.S., Christopher L. Morris, M.D., Ph.D., George Muller, Ph.D., Kyle Chan, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 689.
https://doi.org/10.1182/blood.V108.11.689.689
Published: 2006
Journal Articles

Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.

Laure Moutouh de Parseval, MD, Helen Brady, Ph.D, Dominique Verhelle, PhD, Laura G. Corral, MS, Emilia Glezer, BS, Christopher L. Morris, MD, PhD, Roger Chen, PhD, Kyle Chan, PhD
Journal: Blood
Blood (2005) 106 (11): 2702.
https://doi.org/10.1182/blood.V106.11.2702.2702
Published: 2005
Journal Articles

Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.

Laure Moutouh de Parseval, MD., Helen Brady, PhD., Emila Glezer, MS., Normand Richard, MS., George Muller, PhD., Christopher L. Morris, MD., PhD., Dave Stirling, PhD., Kyle Chan, PhD.
Journal: Blood
Blood (2004) 104 (11): 3740.
https://doi.org/10.1182/blood.V104.11.3740.3740
Published: 2004